Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 19;14(7):e0219137.
doi: 10.1371/journal.pone.0219137. eCollection 2019.

Selective serotonin reuptake inhibitors and risk of epilepsy after traumatic brain injury - A population based cohort study

Jakob Christensen  1 , Henrik Schou Pedersen  2 , Morten Fenger-Grøn  2 , Jesse R Fann  3 , Nigel C Jones  4   5 , Mogens Vestergaard  2
Affiliations

Selective serotonin reuptake inhibitors and risk of epilepsy after traumatic brain injury - A population based cohort study

Jakob Christensen et al. PLoS One. .

Abstract

Objective: Traumatic brain injury (TBI) is common and associated with a marked increased risk of developing epilepsy. Animal studies indicate that treatment with selective serotonin reuptake inhibitors (SSRIs) may increase the risk of epilepsy after TBI. The aim of this study was to investigate whether use of SSRIs modifies the risk of epilepsy after TBI.

Methods: This was a cohort study of 205,715 persons, who suffered a TBI in Denmark from 1996 to 2013. For each person with TBI, we matched 10 reference persons (N = 2,057,150) who were alive on the day of TBI and who had the same age and gender but had no history of TBI. We used a stratified Cox regression to calculate the relative risk of epilepsy after TBI for persons exposed to TBI, SSRI or both after adjustment for income, civil status, medical and neurological comorbidities, severe mental disease, and substance abuse.

Results: The risk of epilepsy was 5.61 times higher for persons who used SSRI at time of TBI (adjusted Hazard Ratio (aHR): 5.61 (95% CI: 4.88; 6.45)), 3.23 times higher for persons who had a TBI but did not use SSRI at time of TBI (aHR: 3.23 (95% CI: 3.12;3.35)), and 1.31 times higher for persons who used SSRI but had no TBI (aHR: 1.31 (95% CI: 1.18; 1.45)) compared to persons unexposed to both TBI and SSRI.

Conclusions: This large population based cohort study showed that people using SSRI at the time of a TBI had higher risk of developing epilepsy compared to people not using SSRI at the time of TBI. The results are in line with those of animal studies and calls for further studies to evaluate whether the association is due to SSRIs or to the underlying disease (e.g. depression or anxiety).

PubMed Disclaimer

Conflict of interest statement

JC received honoraria from serving on the scientific advisory board of UCB Nordic and Eisai AB, received honoraria from giving lectures from UCB Nordic and Eisai AB, and received funding for a trip from UCB Nordic. The other authors report no conflicts of interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Risk of epilepsy after traumatic brain injury (TBI) and use of Selective Serotonin Reuptake Inhibitors (SSRIs) at time of injury.
See this image and copyright information in PMC

References

    1. Thurman DJ, Begley CE, Carpio A, Helmers S, Hesdorffer DC, Mu J, et al. The primary prevention of epilepsy: A report of the Prevention Task Force of the International League Against Epilepsy. Epilepsia. 2018;59(5):905–14. Epub 2018/04/11. 10.1111/epi.14068 . - DOI - PMC - PubMed
    1. Taylor CA, Bell JM, Breiding MJ, Xu L. Traumatic Brain Injury-Related Emergency Department Visits, Hospitalizations, and Deaths—United States, 2007 and 2013. MMWR Surveill Summ. 2017;66(9):1–16. Epub 2017/03/17. 10.15585/mmwr.ss6609a1 - DOI - PMC - PubMed
    1. Majdan M, Plancikova D, Brazinova A, Rusnak M, Nieboer D, Feigin V, et al. Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis. The Lancet Public health. 2016;1(2):e76–e83. Epub 2017/12/19. 10.1016/S2468-2667(16)30017-2 . - DOI - PubMed
    1. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019. Epub 2019/03/19. 10.1016/s1474-4422(18)30499-x . - DOI - PMC - PubMed
    1. DeGrauw X, Thurman D, Xu L, Kancherla V, DeGrauw T. Epidemiology of traumatic brain injury-associated epilepsy and early use of anti-epilepsy drugs: An analysis of insurance claims data, 2004–2014. Epilepsy Res. 2018;146:41–9. Epub 2018/08/03. 10.1016/j.eplepsyres.2018.07.012 . - DOI - PMC - PubMed

Publication types

Substances